CCL5 and cancer: On the other hand, another hub-chemokine, CCL5, is also found to be capable of inducing the immunosuppression in the tumor microenvironment and subsequent cancer progression and poor prognosis in KIRC via CCL5-dependent mast cell infiltration 30.